{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:16:45Z","timestamp":1775855805261,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,6,16]],"date-time":"2013-06-16T00:00:00Z","timestamp":1371340800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s11064-013-1091-3","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T10:57:18Z","timestamp":1371293838000},"page":"1850-1860","source":"Crossref","is-referenced-by-count":25,"title":["Suppression of Hypothalamic\u2013Pituitary\u2013Adrenal Axis by Acute Heroin Challenge in Rats During Acute and Chronic Withdrawal from Chronic Heroin Administration"],"prefix":"10.1007","volume":"38","author":[{"given":"Yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Leri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,16]]},"reference":[{"key":"1091_CR1","first-page":"232","volume":"1","author":"MJ Kreek","year":"1996","unstructured":"Kreek MJ (1996) Opiates, opioids and addiction. Mol Psychiatry 1:232\u2013254","journal-title":"Mol Psychiatry"},{"key":"1091_CR2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","volume":"11","author":"A Mansour","year":"1988","unstructured":"Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308\u2013314","journal-title":"Trends Neurosci"},{"key":"1091_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.brainres.2009.11.015","volume":"1314","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Proudnikov D, Yuferov V, Kreek MJ (2010) Drug-induced and genetic alterations in stress-responsive systems: implications for specific addictive diseases. Brain Res 1314:235\u2013252","journal-title":"Brain Res"},{"key":"1091_CR4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1973.03220060039009","volume":"223","author":"MJ Kreek","year":"1973","unstructured":"Kreek MJ (1973) Medical safety and side effects of methadone in tolerant individuals. JAMA 223:665\u2013668","journal-title":"JAMA"},{"key":"1091_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0143-4179(84)90081-7","volume":"5","author":"MJ Kreek","year":"1984","unstructured":"Kreek MJ, Ragunath J, Plevy S, Hamer D, Schneider B, Hartman N (1984) ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides 5:277\u2013288","journal-title":"Neuropeptides"},{"key":"1091_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-3223(86)90150-2","volume":"21","author":"TR Kosten","year":"1986","unstructured":"Kosten TR, Kreek MJ, Raghunath J, Kleber HD (1986) Cortisol levels during naltrexone maintenance treatment in ex-opiate addicts. Biol Psychiatry 21:217\u2013220","journal-title":"Biol Psychiatry"},{"key":"1091_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0026-0495(97)90289-4","volume":"46","author":"JA Culpepper-Morgan","year":"1997","unstructured":"Culpepper-Morgan JA, Kreek MJ (1997) HPA axis hypersensitivity to naloxone in opioid dependence: a case of naloxone induced withdrawal. Metabolism 46:130\u2013134","journal-title":"Metabolism"},{"key":"1091_CR8","first-page":"1287","volume":"255","author":"DM Ignar","year":"1990","unstructured":"Ignar DM, Kuhn CM (1990) Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo\u2013pituitary\u2013adrenal axis secretion in the rat. J Pharmacol Exp Ther 255:1287\u20131295","journal-title":"J Pharmacol Exp Ther"},{"key":"1091_CR9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(90)90499-V","volume":"182","author":"JA Martinez","year":"1990","unstructured":"Martinez JA, Vargas ML, Fuente T, Garcia JDR, Milanes MV (1990) Plasma beta-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal. Eur J Pharmacol 182:117\u2013123","journal-title":"Eur J Pharmacol"},{"key":"1091_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1677\/joe.1.06960","volume":"191","author":"Y Zhou","year":"2006","unstructured":"Zhou Y, Bendor J, Hofmann L, Randesi M, Ho A, Kreek MJ (2006) Mu opioid receptor and orexin\/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol 191:137\u2013145","journal-title":"J Endocrinol"},{"key":"1091_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archpsyc.63.3.324","volume":"63","author":"R Sinha","year":"2006","unstructured":"Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006) Stress-induced cocaine craving and hypothalamic\u2013pituitary\u2013adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:231\u2013324","journal-title":"Arch Gen Psychiatry"},{"key":"1091_CR12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archgenpsychiatry.2009.9","volume":"66","author":"KT Brady","year":"2009","unstructured":"Brady KT, McRae AL, Moran-Santa Maria MM, DeSantis SM, Simpson AN, Waldrop AE, Back SE, Kreek MJ (2009) Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. Arch Gen Psychiatry 66:422\u2013430","journal-title":"Arch Gen Psychiatry"},{"key":"1091_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0006-8993(91)90836-K","volume":"553","author":"KP Gudehithlu","year":"1991","unstructured":"Gudehithlu KP, Tejwani GA, Bhargave HN (1991) b-Endorphin and methionine enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Brain Res 553:284\u2013290","journal-title":"Brain Res"},{"key":"1091_CR14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","volume":"89","author":"L Merrer Le","year":"2009","unstructured":"Le Merrer L, Becker JAJ, Befort K, Kieffer BL (2009) Reward processing by the opioid system in the brain. Physiol Rev 89:1379\u20131412","journal-title":"Physiol Rev"},{"key":"1091_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02896854","volume":"1","author":"I Mocchetti","year":"1989","unstructured":"Mocchetti I, Ritter A, Costa E (1989) Down-regulation of proopiomelanocortin synthesis and b-endorphin utilization in hypothalamus of morphine-tolerant rats. J Mol Neurosci 1:33\u201338","journal-title":"J Mol Neurosci"},{"key":"1091_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0006-8993(90)90066-K","volume":"519","author":"DM Bronstein","year":"1990","unstructured":"Bronstein DM, Przewlocki R, Akil H (1990) Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res 519:102\u2013111","journal-title":"Brain Res"},{"key":"1091_CR17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000125597","volume":"52","author":"MJ Kelly","year":"1990","unstructured":"Kelly MJ, Loose MD, Ronnekleiv OK (1990) Opioids hyperpolarize beta-endorphin neurons via mu-opioid activation of a potassium conductance. Neuroendocrinology 52:268\u2013275","journal-title":"Neuroendocrinology"},{"key":"1091_CR18","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","volume":"23","author":"D Georgescu","year":"2003","unstructured":"Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ, Dileone RJ (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106\u20133111","journal-title":"J Neurosci"},{"key":"1091_CR19","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1523\/JNEUROSCI.5447-07.2008","volume":"28","author":"Y Li","year":"2008","unstructured":"Li Y, van den Pol AN (2008) Mu-opioid receptor-mediated depression of the hypothalamic hypocretin\/orexin arousal system. J Neurosci 28:2814\u20132819","journal-title":"J Neurosci"},{"key":"1091_CR20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","volume":"164","author":"GF Koob","year":"2007","unstructured":"Koob GF, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149\u20131159","journal-title":"Am J Psychiatry"},{"key":"1091_CR21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.npp.1301419","volume":"33","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, Leri F, Cummins E, Hoeschele M, Kreek MJ (2008) Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 33:226\u2013236","journal-title":"Neuropsychopharmacology"},{"key":"1091_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00213-011-2380-7","volume":"219","author":"KM Seip","year":"2012","unstructured":"Seip KM, Reed B, Ho A, Kreek MJ (2012) Measuring the incentive value of escalating doses of heroin in heroin-dependent Fischer rats during acute spontaneous withdrawal. Psychopharmacology 219:59\u201372","journal-title":"Psychopharmacology"},{"key":"1091_CR23","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/sj.npp.1300271","volume":"28","author":"H Houshyar","year":"2003","unstructured":"Houshyar H, Gomez F, Manalo S, Bhargava A, Dallman M (2003) Intermittent morphine administration induces dependence and is a chronic stressor in rats. Neuropsychopharmacology 28:1960\u20131971","journal-title":"Neuropsychopharmacology"},{"key":"1091_CR24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coph.2008.12.016","volume":"9","author":"MJ Kreek","year":"2009","unstructured":"Kreek MJ, Zhou Y, Butelman ER, Levran O (2009) Opiate and cocaine addiction: from bench to clinic and back to bench. Cur Opin Pharmacol 9:74\u201380","journal-title":"Cur Opin Pharmacol"},{"key":"1091_CR25","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/jcem-38-5-736","volume":"38","author":"JM George","year":"1974","unstructured":"George JM, Reier CE, Lanese RR, Rower M (1974) Morphine anesthesia blocks cortisol and growth hormone response to surgical stress in humans. J Clin Endocrinol Metab 38:736\u2013741","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1213\/00000539-198201000-00004","volume":"61","author":"MJ Cowen","year":"1982","unstructured":"Cowen MJ, Bullingham RE, Paterson GM, McQuay HJ, Turner M, Allen MC, Moore A (1982) A controlled comparison of the effects of extradural diamorphine and bupivacaine on plasma glucose and plasma cortisol in postoperative patients. Anesth Analg 61:15\u201318","journal-title":"Anesth Analg"},{"key":"1091_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.0.1630261","volume":"163","author":"Y Zhou","year":"1999","unstructured":"Zhou Y, Spangler R, Maggos CE, Wang XM, Han JS, Ho A, Kreek MJ (1999) Hypothalamic\u2013pituitary\u2013adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress. J Endocrinol 163:261\u2013267","journal-title":"J Endocrinol"},{"key":"1091_CR28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1365-2826.2003.01037.x","volume":"15","author":"ML Laorden","year":"2003","unstructured":"Laorden ML, Milanes MV, Angel E, Tankosic P, Burlet A (2003) Quantitative analysis of corticotrophin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study. J Neuroendocrin 15:586\u2013591","journal-title":"J Neuroendocrin"},{"key":"1091_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0167-0115(86)90022-4","volume":"16","author":"PM Plotsky","year":"1986","unstructured":"Plotsky PM (1986) Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats. Reg Pept 16:235\u2013242","journal-title":"Reg Pept"},{"key":"1091_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000123364","volume":"35","author":"JC Buckingham","year":"1982","unstructured":"Buckingham JC (1982) Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 35:111\u2013116","journal-title":"Neuroendocrinology"},{"key":"1091_CR31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0169-328X(96)00084-8","volume":"41","author":"SL Wardlaw","year":"1996","unstructured":"Wardlaw SL, Kim J, Sobieszczyk S (1996) Effect of morphine on pro-opiomelanocortin gene expression and peptide levels in the hypothalamus. Mol Brain Res 41:140\u2013147","journal-title":"Mol Brain Res"},{"key":"1091_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(97)00348-3","volume":"55","author":"Y Fang","year":"1998","unstructured":"Fang Y, Kelly MJ, R\u00f8nnekleiv OK (1998) Proopiomelanocortin (POMC) mRNA expression: distribution and region-specific down-regulation by chronic morphine in female guinea pig hypothalamus. Mol Brain Res 55:1\u20138","journal-title":"Mol Brain Res"},{"key":"1091_CR33","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0507480102","volume":"102","author":"B Boutrel","year":"2005","unstructured":"Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L (2005) Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA 102:19168\u201319173","journal-title":"Proc Natl Acad Sci USA"},{"key":"1091_CR34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","volume":"437","author":"GC Harris","year":"2005","unstructured":"Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556\u2013559","journal-title":"Nature"},{"key":"1091_CR35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2009.08.028","volume":"1314","author":"R Sharf","year":"2010","unstructured":"Sharf R, Sarhan M, DiLeone RJ (2010) Role of orexin\/hypocretin in dependence and addiction. Brain Res 1314:130\u2013138","journal-title":"Brain Res"},{"key":"1091_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(90)90106-L","volume":"534","author":"KD Carr","year":"1990","unstructured":"Carr KD (1990) Effects of antibodies to dynorphin A and beta-endorphin on lateral hypothalamic self-stimulation in ad libitum fed and food-deprived rats. Brain Res 534:8\u201314","journal-title":"Brain Res"},{"key":"1091_CR37","first-page":"341","volume":"51","author":"JM Ree van","year":"1999","unstructured":"van Ree JM, Gerrits MA, Vanderschuren LJ (1999) Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 51:341\u2013396","journal-title":"Pharmacol Rev"},{"key":"1091_CR38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.095380","volume":"317","author":"S Negus","year":"2006","unstructured":"Negus S (2006) Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine and methadone. J Pharmacol Exp Ther 317:711\u2013723","journal-title":"J Pharmacol Exp Ther"},{"key":"1091_CR39","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/sj.npp.1301008","volume":"31","author":"SA Chen","year":"2006","unstructured":"Chen SA, O\u2019Dell LE, Hoefer ME, Greenwell TN, Zorrilla EP, Koob GF (2006) Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology 31:2692\u20132707","journal-title":"Neuropsychopharmacology"},{"key":"1091_CR40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/jpet.108.139196","volume":"326","author":"ZD Cooper","year":"2008","unstructured":"Cooper ZD, Truong YN, Shi YG, Woods JH (2008) Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. J Pharmacol Exp Ther 326:920\u2013929","journal-title":"J Pharmacol Exp Ther"},{"key":"1091_CR41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biopsych.2007.05.001","volume":"63","author":"J Kakko","year":"2008","unstructured":"Kakko J, von Wachenfeldt J, Svanborg KD, Lidstr\u00f6m J, Barr CS, Heilig M (2008) Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence. Biol Psychiatry 63:172\u2013177","journal-title":"Biol Psychiatry"},{"key":"1091_CR42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0893-133X(00)00222-0","volume":"24","author":"JH Schluger","year":"2001","unstructured":"Schluger JH, Borg L, Ho A, Kreek MJ (2001) Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Neuropsychopharmacology 24:568\u2013575","journal-title":"Neuropsychopharmacology"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-1091-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-013-1091-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-1091-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T15:34:34Z","timestamp":1563204874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-013-1091-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,16]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1007\/s11064-013-1091-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,16]]}}}